The strong beat and raised guidance confirm DaVita's operational execution. Monitor for potential upside to FY guidance as the year progresses; the continued buyback supports EPS growth. Competitor FMS may also benefit from positive sector sentiment.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 6 $191.76entry
- T+1 · 6mo ago +1.87%α +2.20% · $195.35
- T+5 · 6mo ago +4.58%α +3.45% · $200.54
- T+20 · 6mo ago +1.71%α −1.07% · $195.03
- T+60 · 4mo ago +24.56%α +23.49% · $238.86
Price Chart
How similar events traded
Executive Summary
DaVita reported Q1 2026 revenue of $3.416B (+6% YoY) and GAAP diluted EPS of $2.87, beating the Street consensus of $2.41 by 19%. The company raised its FY2026 adjusted EPS guidance to $14.10-$15.20 from $13.60-$15.00, signaling sustained operating momentum and margin expansion.
Key Financial Metrics
Key Facts
- Revenue of $3.416B (+6% YoY) beat consensus.
- GAAP diluted EPS of $2.86 (actually $2.87) beat Street consensus of $2.41 by 19%.
- FY2026 adjusted EPS guidance raised to $14.10-$15.20 from $13.60-$15.00.
- Aggressive buyback: 3.0M shares for $403M in Q1, plus 2.0M for $302M after quarter-end.
- Integrated kidney care risk-based patients declined to 62,600 from 66,000 sequentially.
Financial Impact
EPS beat by $0.46 vs consensus, revenue beat by ~$56M vs notional consensus, guidance raised at the low end by $0.50.
Risk Factors
- Declining integrated kidney care patient count may signal challenges in value-based care.
- Rising operating costs (patient care costs per treatment up 3% YoY) could pressure margins.
- Potential regulatory changes (Medicare reimbursement, OBBBA) remain unknown.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000927066-26-000060 |
| Document: dva-20260505.htm | 0000927066-26-000060 |
| Document: 0000927066-26-000060-index-headers.html | 0000927066-26-000060 |
| Document: 0000927066-26-000060-index.html | 0000927066-26-000060 |
| Document: 0000927066-26-000060.txt | 0000927066-26-000060 |
| 8-K Data (Synthetic) | 0000927066-26-000060 |
Track record
9 reports on DVA
The track record builds as more bullish or bearish reports settle.
Filters
- Oct 29, 202618d ago 8-K Mixed 5/10 No price data
- Oct 29, 202618d ago Press Release Bullish 6/10 Entry $187.50 Now $174.22 −7.08% settles Jan 28
- Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $183.64 Now $174.22 −5.13% settles Jan 21
- Aug 4, 202614w ago 8-K Bullish 6/10 Entry $187.61 to $193.31 Now $174.22 −7.14% ▲ +3.04% +3.10% vs SPY
- Jun 15, 202622w ago Court Ruling Neutral 1/10 Entry $208.98 to $181.55 Now $174.22 −16.63% ▼ −13.13% −14.99% vs SPY
- Jun 8, 202623w ago 8-K Mixed 5/10 Entry $198.19 to $178.83 Now $174.22 −12.09% ▼ −9.77% −13.58% vs SPY
- May 18, 202626w ago Insider Cluster Neutral 3/10 Entry $194.38 to $179.17 Now $174.22 −10.37% ▼ −7.82% −13.84% vs SPY
- May 13, 202626w ago Insider Cluster Bearish 6/10 Entry $192.30 to $183.48 Now $174.22 +9.40% ▲ +4.59% +7.91% vs SPY
- May 5, 202627w ago 8-K Bullish 8/10 Viewing Entry $191.76 to $238.86 Now $174.22 −9.15% ▲ +24.56% +23.49% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers